Two quite different methods of inducing histamine release from rat peritoneal mast ceils have been described (1, 2). The first is the nonsemm requiring, homocytotropic antibody-mediated release of histamine examined in the preceding paper; the antigen-antibody-activated esterase involved in this reaction has been distinguished from the first component of rat complement (3). In the second method, histamine is released when serum is added to cells previously sensitized with rabbit anti-rat gamma globulin rabbit anti-RGG. Sensitization results from the interaction of rabbit anti-rat IgG with rat IgG on the surface of the mast cell (2).
(Received for publication 4 April 1966) Two quite different methods of inducing histamine release from rat peritoneal mast ceils have been described (1, 2) . The first is the nonsemm requiring, homocytotropic antibody-mediated release of histamine examined in the preceding paper; the antigen-antibody-activated esterase involved in this reaction has been distinguished from the first component of rat complement (3) . In the second method, histamine is released when serum is added to cells previously sensitized with rabbit anti-rat gamma globulin rabbit anti-RGG. Sensitization results from the interaction of rabbit anti-rat IgG with rat IgG on the surface of the mast cell (2) .
The factors in normal serum required for the latter reaction are inactivated by heating to 56°C for 30 rain, by the presence of ethylenediaminetetraacetate (EDTA), and by prior absorption with an unrelated antigen-antibody aggregate (1) . These findings are consistent with the view that the serum factors are complement, but there is no apparent correlation between the histamine-releasing activity of serum from different species and their content of hemolytic complement (1, 4) . Moreover, Keller (5) showed that rabbit serum genetically deficient in the sixth component of complement would sustain histamine release (6) and concluded that not all the components of complement are required. On the basis of results obtained with the classical complement R reagents, he considered that activation of the first component of complement was necessary but that the second component of complement was not involved (4, 5) in the release of histamine by rabbit anti-rat gamma globulin.
Most previous investigations have sought to relate complement causally to a biologic activity other than immune hemolysis by removing one or another of the components of complement and then testing the resulting "reagent" for the biologic activity in question. A reduction in biologic activity is taken as proof for the requirement of a given component of hemolytic complement. This is obviously a necessary condition for concluding that complement is involved; in view of the unspecific nature of the procedures for removing complement components, it is not, however, a sufficient condition. In the present investigation it was deemed necessary to fulfill two conditions before concluding that a given component of complement was required: (a) a reagent lacking in this component must not sustain histamine release; and (b) the histamine-releasing capacity of the reagent must be restored by the addition of the isolated, purified component in question.
The second aspect of this investigation was the study of the pattern of inhibition by p-nitrophenylethyl phosphonate esters of histamine release by rabbit anti-RGG. For comparison, the activity of the phosphonate esters against the activated first component (Cqa) of rabbit complement bound to sensitized sheep erythrocytes was also determined.
The results obtained have permitted the following comparisons: (a) the specific complement components involved in the complement-dependent, noncytotoxic release of histamine have been compared with those required for immune hemolysis; and (b) a phosphonate-sensitive, antigen-antibody-activated esterase essential to the complement-dependent, release of histamine by rabbit anti-RGG has been compared with the first component of complement and with the esterase involved in homocytotropic antibody-mediated release of histamine.
Materials and Methods
Complement.--Fresh or fresh frozen normal human or rabbit sera were used as sources of whole complement. The sera were dialyzed against 500 ml of glucose-free. Tyrode's buffer, which was changed 3 times over a 6 hr period.
Purified Complement Components.--First component of human complement (C'I) was reconstituted by the combination of the subcomponents, C'lq, C'lr, and C'ls (W.R.U., 29 October 1965) kindly supplied by Dr. Irwin H. Lepow (7, 8) . Highly purified human second component of complement (C'2) containing EDTA 10 -8 M and dithioerythritol 10 -4 M was obtained from Dr. Lepow (9) ; Dr. Hans Miiller-Eberhard supplied a highly purified C~2 preparation (20, 190 /~g protein per ml) which had not been activated by exposure to molecular iodine (10) . The components C'3 (162 II; C-184 III), (11, 12) , C'4 (30, pool 2; 34) (13), and C'5 (B 40; B 49) (11) were generously made available by Dr. Miil]er-Eberhard. Complement Reagents.--The R1 reagent, human serum deficient in the first component of complement (Cq), was prepared by dialysis according to Mayer (14) . The reagent was fortified either with an equal volume of serum previously heated for 20 min at 56°C (R1 + H) or with highly purified C'3, C'4, and C'5 (R1 + C'3 + C'4 + C'5) in concentrations of 790, 135, and 36/~g per ml respectively.
Certain reagents were sera from men or animals with an inborn or acquired, selective deftciency of a single component of complement. C'2-deficient sera were obtained from 2 siblings with a genetic deficiency in the second component of complement (15) . Sera predominantly deficient in C'3 were obtained from 2 patients with renal disease; these sera were furnished by Dr. Fred Rosen (16) . Sera from rabbits with a genetic deficiency in C'6 (6, 17) were supplied both by Dr. Klaus Rother and by Dr. Carlos Biro and Dr. Charles C. Cochrane.
Human sera deficient in C'3 and C'4 or in C'3, c'g, and C'5 were prepared by treatment with 0.5 ~ or 1.0 ~s KSCN respectively, followed by exhaustive dialysis (18) . These two reagents were supplied by Dr. Miiller-Eberhard.
Material for InMbigtm St~ie~.--The buffers and the p-nitrophenylethylalkyl, phenylalkyl, chloroaikyl, and aminoalkyl phosphonates were those previously described (3). Partially purified rabbit C'la was isolated from rabbit serum in the same manner as rat C'la (3). The red cell intermediate, EAC'la tab, 4 gp was prepared as described for EAC'la rat, 4 gp except for the use of rabbit C'la in place of rat C'la.
Preparation of Sensitized Mast Cells (MAgAb)
--The peritoneal cell suspensions were harvested from rats 10 to 20 wk of age (2) . These cells were washed, pooled, and washed again (3). The rabbit anti-rat gamma globulin (Ra anti-RGG) 17 used to sensitize the cells has been described (1) . In a typical experiment sensitization was achieved by interacting 18 ml of a cell suspension (3) for 5 rain at 37°C with an equal volume of Ra anti-RGG diluted 1:375. Mter sensitization the cells were washed twice, resuspended in 30 ml Tyrode's-gelatin buffer, and stored at 4°C.
Preparation of Cell in the MAgAbC'la hu StaCe.--The pool of sensitized cells was divided
into equal portions, sedimented, and resuspended in only 0.5 ml iced Tyrode's-gelatin buffer. One portion received serially 0.08 ml C'lq, 0.08 ml C'lr, and 0.08 ml C'ls, while the other received 0.24 ml of Tyrode's-gelatin buffer. The reaction mixtures were incubated at 37°C for 5 rain with gentle agitation, diluted with 10 ml buffer, sedimented at 4°C at 400 g for 4 min, resuspended in 18 ml Tyrode's-gelatin buffer, and stored at 4°C.
Reconstitugon of Complement Activity of Complement-Deficient
Reagents.--Six, 11 (MiillerEberhard), and 39 (Lepow) units of C'2 were added to I ml aliquots of the C'2 deficient serum to restore its complement activity. Increasing amounts of C'3, 158, 316, and 632/~g, were added to 1 mi aliquots of nephritic sera with restoration of hemolytic activity; as a control 84/~g of C'4 was added to another aliquot of the same sera. Serum treated with 0.5 ~t KSCN to produce a deficiency in C'4 and C'3 was reconstituted by adding 84/~g of C'4 and varying ammmts of C'3: 395, 494, 987, or 1974/~g per ml; as a control 84/~g of C'4 and 395 or 494/~g of C'3 were added alone. Serum treated with 1.0 M KSCN to produce a deficiency of C'4, C'3, and C'5 was restored by adding 151/~g of C'4, 884/~g of C'3, and 104/~g of C'5 per mi; as a control only C'3 and C'4 were added to an aliquot of the same reagent.
Hemolytic Assays.--The second component of human complement was measured using EAC'la sp, 4 gp cells as described (19) . The assay measures human C'2 as long as human C'4 is also present in the serum or reagent being titrated (15, 20, 21) .
Whole complement activity, man or rabbit, was assayed by a modification of the procedure of Kent et al. (22) . The usual 1.5 ml reaction volume (0.6 ml of 2.5 × I0 s EA, diluent, and complement) was incubated for ~ hr at 37°C, 1 rnl of iced diluent added, the cells sedimented by centrifugation, and the supematant fluids decanted and read in a Beckman spectrophotometer at 540 mu. The optical density of the supernatant fluids was expressed as per cent hemolysis, plotted in the usual manner to determine the 50% end point, and the CH60 titer calculated.
In the assay of R1, EAC'la cells were prepared by treating 20 ml of 5 X l0 s EA with 0.8 ml respectively of C'lq, C'I~. and C'ls added serially. The cells were incubated for 5 rain at 37°C, sedimented, washed once in iced buffer, and restandardized to 2.5 X 10s cells per ml. These cells were then used in the modified Kent procedure as described above.
The Complement-Dependent Rdease of Histamine by Rabbit Anti-RGG.--Sensitized cells stored at 4°C in Tyrode's-gelatin buffer were divided into 1.0 ml aliquots with a volumetric pipette. The cells were sedimented and resuspended in 2 ml Tyrode's-gelatin. Following preincubation at 37°C, 0.1 ml of normal rabbit or human serum, complement deficient serum, or reconstituted serum was added. The reaction mixture was incubated for 7 rain at 37°C, and the cells were then sedimented at 400 g for 4 rain. The superuatant fluid was decanted and assayed for histamine; residual histamine in the cells was also determined. Each variable was studied in three replicate tubes; two received serum, and the third served as a control for spontaneous histamine release. Unsensitized cells from the same pool were always reacted with the source of complement to exclude any nonspecific histamine release by serum alone. Duplicate samples gave values for histamine release which varied by less than 3% of the mean value.
In the experiments concerned with the role of C'la, three different cell preparations were used; unsensitized cells, sensitized cells, and cells in the MAgAbC'la state. Otherwise, the procedure was exactly as described above.
Inhibition of Complement-Dependent Histamine Release by the Phosphenate Esters.--The
pool of mast cells sensitized with rabbit anti-RGG was aliquoted and sedimented as described above and then resuspended in 2 ml Tyrode's-gelatin buffer with or without the various phosphonate esters. The solutions of the phosphonate esters were prepared as described (3). Following preincubation at 37°C, 0.1 ml of rabbit or human serum was added as a source of complement. The reaction mixture was incubated 7 rain, and the cells were then sedimented at 400 g for 4 rain. The supernatant fluid was decanted and assayed for histamine; residual histamine in the cells was also determined. Each variable was studied in three replicate tubes; two received serum, and the third served as a control for spontaneous histamine release.
Enzymatic Hydrolysis of the Pkosphonale Esters by Rabbit Serum.--The rates of enzymatic
hydrolysis of the phosphonate esters by rabbit serum were tested as before (23) except that Tyrode's buffer was employed and the final concentration of rabbit serum was 5%, the same as that used in the complement-dependent release of histamine by rabbit anti-RGG.
Inhibitgon of Hemolytic Complement by the Phosphonate
Esters.--The inhibition of whole rat and rabbit complement by the phosphonate esters was studied as described (24) . The procedure for determining the activity of the various phosphonate esters against rabbit C'la was identical to that used in the study of rat C'la (3).
RESULTS

Time Course of Complement-Dependent Histamine Release by Rabbit Anti-
RGG.--Histamine could not be detected in the supernatant fluid until 2 rain after the addition of rabbit serum to the sensitized cells. Virtually all the histamine was released between the 2nd and 5th rain.
Requirements for Complement Components
Requirement for Crla.--The role of C'la was investigated by observing the effect of serum deficient in C'la on cells in the MAgAb or MAgAbC'la state (Table I ). An R1 reagent fortified with either heated normal human serum (R1 + H) or highly purified components (R1 + C'4 + C'3 + C'5) gave 12 % histamine release from mast ceils in the MAgAbCtla state, whereas R1 or H alone failed to release histamine from these cells. These same reagents--R1, H, R1 + H, R1 + Ct3 + Cr4 + C'5--failed to release histamine from cells in the MAgAb state because C'la was lacking from the reaction mixture. These reagents also failed to release histamine from unsensitized cells pretreated with C'la in the same manner as used in the preparation of MAgAbC'la cells. When an EACqa cell was used to measure hemolytic activity, the fortified R1 preparations had 28 CHs0 units per ml, whereas the R1 alone contained only 3 CHs0 units per ml. None of these reagents--R1, H, R1 + H, R1 + C'4 + C'3 + C'5--had appreciable hemolytic activity for EA because C'la was lacking from the reaction mixture.
Requirement for C'2.--The role of C~2 was investigated by using serum genetically deficient in C'2 before and after restoration with highly purified human C'2. Neither the deficient nor the reconstituted serum released histamine from unsensitized mast cells. The C'2-deficient serum failed to release histamine from sensitized cells. With the addition of purified C'2 there was a linear relationship between the C'2 units added and the percentage of histamine released ( * --, MAgAb or EA; and +, MAgAbCqa or EAC'la.
The relationship held using two different preparations of C'2 purified by different methods (9, 10) . Requirement for C'3.--The role of C'3 was studied using nephritic sera before and after restoration of hemolytic activity with purified human C'3. Neither the deficient nor the reconstituted serum released histamine from unsensitized mast cells. A deficient serum, even when fortified with C~4, failed to release histamine from sensitized cells (Table II) . However, the further addition of 316 #g of C~3 gave 7 % histamine release and raised the hemolytic titer to 39 CHs0 units per ml.
The 7 % histamine release obtained with 0.1 ml of reconstituted nephritic serum was approximately the same as the release obtained with 0.06 ml of normal serum (Table II) . In the 0.06 ml normal serum there were 5.5 CH~o units compared to 3.9 CHs0 units in 0.1 ml of reconstituted serum, indicating a reasonable correspondence between restoration of histamine-releasing activity and hemolyric capacity of the nephritic serum by purified C'3.
KSCN-treated serum, deficient in Ct4 and C'3, before and after restoration of hemolytic activity by adding both components. As shown in Table III , experiment A, neither the addition of Cr4 or CP3 alone restored histamine-releasing or hemolytic activity. When both components were added together, hemolytic ac- tivity was restored, and the reagent gave 12 % histamine release from sensitized mast cells. This indicates a need for C'4 as well as C'3 in complement-dependent, histamine release.
In experiment B, the 0.5 ~ KSCN reagent was restored by adding a fixed amount of C~4 and increasing amounts of C~3. Addition of C~4 alone, 84 #g per ml, had no effect, whereas the concomitant introduction of 494 and 987/~g of C'3 per ml gave 9 and 13 % histamine release, respectively. Increasing the concentration of C'3 to 1974 #g per ml gave no further increment in histamine release under these experimental conditions. None of the reagents used in experiment A and B released histamine from unsensitized mast cells.
Requirement for C'5.--The role of C'5 was examined by using 1.0 M KSCNtreated serum, deficient in C'4, C'3, and C'5. As shown in Table III , experiment C, the addition of C'4 and C'3 failed to yield a reagent capable of releasing histamine from sensitized cells even when 0.2 ml as added so as to give a final concentration of 10 70 rather than the usual 5 70 undiluted serum. The further addition of C'5 to this reagent did give 6 70 histamine release. None of the re- * ml of undiluted serum added to complete reaction volume of 2.0 ml. ~t Per ml of undiluted serum. agents released histamine from unsensitized cells in a final concentration of 10 % indiluted serum.
In another experiment with different preparations of the complement components, the addition of C'4, C'3, and C'5 to 1.0 M KSCN-treated serum yielded a reagent which gave 11 70 histamine release. The addition of C'4 and C'3 alone or together failed to produce a reagent capable of giving histamine release. In this experiment the hemolytic titers of the reagents were not obtained because of insufficient material.
Inhibition by Phosphonate Esters
Effect of Phosphonate Esters on Inhibition of C'la.--The inhibition of rat, rabbit, and guinea pig C'la by the phenylalkyl phosphonates and by the chloroalkyl phosphonates is seen in Fig. 2 . The inhibition of rabbit C'la was determined for this study, that of guinea pig C'la (25) and rat C'3a (3) from previous studies. Table IV shows the inhibition of rabbit, rat, and guinea pig C'la by pentyl, 5-aminopentyl, and 5-chloropentyl phosphonate.
The great similarity in the patterns of inhibition of the enzymes from three different species is evident in Fig. 2 and Table IV is that benzyl phosphonate shows a peak activity against guinea pig C'la, whereas the phenyl phosphonate gives maximal inhibition of rabbit and rat Cqa. reaction. Dose-response curves of only 5 compounds were investigated, since these compounds had already been shown to be functionally free of impurity (3). Fig. 3 shows the linear relation of per cent inhibition of histamine release to the concentration of phenyl, benzyl, 3-chloropropyl, 5-chloropentyl, and 5-aminopentyl phosphonate. The release of histamine from sensitized mast cells incu-bated with the phosphonate esters in the absence of added rabbit serum did not increase with increasing concentrations of these phosphonate esters.
Effect of Phosphonate Esters on
Lack of Inhibitory Effect of Phosphonate Esters When Added to and Removed from Rabbit Serum or Sensitized Cells before Interaction of Serum and Sensitized
Cdts.--In the first group of experiments, the effect of the phosphonates on serum in the absence of sensitized mast cells was tested. 100th ml of phenyl, 5-aminopentyl, and 4-chlorobutyl phosphonate in acetone was added to 1 ml samples of normal rabbit serum at a final concentration of 3 X 10 -~, 4 X 10-", and 9 X 10 -~ x~ respectively. The mixtures of serum and phosphonate were incubated for 20 min at 37°C and gradually turned yellow from the p-nltrophenyl liberated by the enzymatic breakdown of the phosphonate ester (23) . For a control 0.01 ml of acetone was added to 1 ml normal rabbit serum and treated in * Rabbit serum treated with phosphonate, dialyzed, and used to release histamine from sensitized mast ceUs as described in Materials and Methods. the same way. At the end of 20 rain, the serum samples were dialyzed in the cold for 6 hr against 3 changes of glucose-free Tyrode's buffer to remove unreacted phosphonate. As seen in Table V , none of the phosphonate ester inhibitors affected the histamine-releasing capacity of the rabbit serum when removed prior to adding the serum to the sensitized mast cells. These same phosphonates gave 75 to 90 % inhibition when present in these concentrations at the time serum was added to sensitized cells.
In order to test the effect of these inhibitors on the mast cells, sensitization by Ra anfi-RGG was carried out in their presence. Sensitization in the presence or absence of the phosphonate esters was allowed to proceed for 3 man at 37°C, and then the cells were sedimented, washed, resuspended, and exposed to fresh normal rabbit serum in the usual manner. As seen in Table VI , there was no interference with histamine release.
These results indicate that the phosphonate esters act only on an antigen-antibody-activated esterase which appears following interaction of the sensitized mast cells and normal rabbit serum.
The Effect of Structure on the Activity of the Pkosphonate Inhibitors.-- Fig. 4 , A demonstrates that the degree of inhibition given by the phenylalkyl phosphohates increases regularly with increasing distance of the benzene ring from the phosphorous atom. In the chloroalkyl series (Fig. 4, B) , the inhibitory activity increased regularly with increasing chain length for the entire series tested; i.e., from the 2-chloroethyl to the 5-chloropentyl phosphonates. Both the 5-chloropentyl and 5-aminopentyl phosphonates were superior to the pentyl phosphohate in preventing histamine release (Table VII) .
Most of the studies analyzing the role of complement components in histamine release were done with human reagents and purified human components. It was therefore necessary to be certain that the same relationship of phosphonate structure to inhibition of histamine release was observed with human as with rabbit complement. Two pairs of phosphonate esters, chosen to provide a critical comparison, were used. As seen in Table VIII, the phenylethyl was distinctly better than the benzyl phosphonate, and the 5-chloropentyl was superior to the 4-chlorobutyl phosphonate as an inhibitor of histamine release from sensitized mast cells by human serum. These are the same relationships observed when rabbit serum is used as the complement source (Table VIII and Fig. 4) .
Effect of Enzymatic Hydrolysis of the Phos phonates by Rabbit
Serum.--Hydrolysis of the phosphonate esters by the mast cells is negligible and can be disregarded. Rabbit serum, however, contains an enzyme which hydrolyzes the phosphonates (23) . The resulting ethoxy phosphonic acids are inactive as inhibitors. It was also necessary to be certain that the relationship of structure to inhibitory activity observed was not due in part to differences in the relative susceptibility of the phosphonates to enzymatic inactivation by rabbit serum. The concentrations of the phosphonates used were the highest employed in the study of their activity against histamine release. In the phenylalkyl series the phenyl phosphonate was hydrolyzed most rapidly (5.5 X 10 -5 ~/liter/5 rain) and the benzyl phosphonate least rapidly; the phenylpropyl was broken down faster than the phenylethyl phosphonate. These results make it impossible for the differential rates of hydrolysis to be responsible for the pattern of inhibition of histamine release given by the phenylalkyl phosphonate series. Furthermore, the hydrolysis rate of even the most susceptible member, the phenyl phosphonate, was not sufficient to be of significance in the inhibition experiments.
In the chloroalkyl series, the 2-chloroalkyl was hydrolyzed most rapidly (7.2 10 -4 ~r/liter/5 min), and the 3-chloropropyl phosphonate the least rapidly. This pattern, as well as the rates, makes it impossible for hydrolysis to contribute to the pattern of inhibition of histamine release by the chloroalkyl phosphonate series.
TABLE VIII
Comparison of Human and Rabbit Serum as Complement Sources on the Inhibition of Histamine
Release by Phosphonate Esters 
DISCUSSION
The data presented herein on the complement-dependent release of histamine by rabbit anti-RGG are concerned with both the number of complement components involved and the character of the antigen-antibody activated, phosphonate-sensitive esterase required for histamine release. The observations on these two points will be discussed separately and then integrated into a single reaction scheme.
Requirement for Complement Components.--There is an absolute requirement for C'I, C'2, C'4, C'3, and C'S in releasing histamine from rat peritoneal mast cells sensitized with Ra anti-RGG. This conclusion is based upon the restoration of histamine-releasing capacity by adding highly purified complement components to sera deficient in one or more of these components (Tables I to III, Fig.  I ). Of special advantage was the availability of sera from humans and rabbits with inborn or acquired deficiencies in a single component of complement.
With the addition of highly purified human C~2 (Fig. I) to serum genetically deficient in this component, there was a linear relationship between the number of hemolytic C'2 units added and the percentage of histamine released from sensitized mast cells. There was also a reasonable correspondence between the restoration of histamine-releasing and hemolytic capacity of nephritic sera by the addition of highly purified human C'3 (Table II) . The correlation between restoration of hemolytic activity and histamine-releasing capacity of the C~2 -and C'3-deficient sera rests upon the fact that these natural reagents are deficient in only a single complement component (15, 16) .
In contrast, the artificially prepared R reagents are both incompletely depleted of the desired component and partially deficient in many others. The partial deficiency of components other than the desired one is seen clearly in the results obtained with the R1 reagent ( Table I ). The R1 alone gave neither histamine release nor hemolytic activity with cells in the MAgAbC'la hu or EAC'la hu state, respectively. The R1 had to be fortified with heated serum or purified components, CP4, C~3, and C'5, before demonstrating histamine-releasing or hemolytic activity.
Direct reconstitufion of an R1 + H reagent with purified human CPla prepared from the subcomponents failed to relase histamine from sensitized mast cells. Restoration was only effective when C'la was already present on the senstitized mast cell. Completely analogous results are obtained when Cqa is added to an R1 in the presence of EA (7, 26) . The ability of fluid phase Ctla to inactivate CP4 and Ct2 in the R1 reagent explains the failure to restore complement activity with this experimental design.
The incomplete depletion of a desired component was observed in attempts to prepare an R2 reagent. An R2 prepared either by dialysis (14) or by dilution (14, 19) was invariably found to contain 10 to 15 % of the initial C'2 concentration, 60 to 90 units per ml of the equivalent undiluted serum when assayed with EAC'la*~, 4~ cells (19, 27) . Reference to Fig. 1 demonstrates that this amount of C~2 is sufficient to give full histamine-releasing activity. This is undoubtedly the explanation for the finding of Keller (5) that an R2 reagent sustains histamine release.
With recognition of their shortcomings, certain artificially prepared reagents were used to demonstrate a requirement for certain complement components in histamine release from sensitized mast cells. With the addition of purified components (Table III) it was possible to demonstrate an association between histamine-releasing and hemolytic capacity.
The ability of serum from complement-deficient rabbits to sustain histamine release by rabbit anti-RGG was reported by Keller (5) ; in Keller's experiments it is possible that C% supplied with the antiserum reconstituted the deficient serum since both were added simultaneously. In the present experiments, cells were sensitized with rabbit anti-RGG and washed twice before being exposed to serum from rabbits genetically deficient in C'6 (6, 28) . The results were not consistent; in early experiments the deficient sera were active, but in later experiments using subsequent bleedings or sera from different donors, there was no activity. Any judgment as to a requirement for C'6 in the release of histamine from mast cells sensitized with rabbit anti-RGG must be deferred until experiments can be performed with deficient serum before and after reconstitution with functionally pure rabbit C%. A definitive investigation as to the role of C'6 could best be carried out by preparing the sensitized mast cell complement intermediates in a fashion analogous to preparation of the sensitized red cell intermediates.The preparation of a sensitized mast cell in the MAgAbC/-la state (Table I) attests to the feasibility of this approach.
Inhibition by Phosphonate Esters.--The inhibition of complement-dependent histamine release by the phosphonate esters is not through an irreversible effect on either the sensitized mast cell (Table VI) or serum complement (Table V) alone. Inhibition occurs only when the phosphonate is present at the time of interaction between the sensitized mast cell and serum complement. Thus, the phosphonate esters must inhibit an antigen-antibody-activated esterase which exists in a phosphonate resistant precursor form until activation by the interaction of the sensitized cell and serum complement.
There is almost a complete disparity in the ability of the phenylalkyl and chloroalkyl phosphonates to inhibit the complement-dependent release of histamine (Fig. 4) and to inhibit Ctla (Fig. 2) . It is clear that the inhibitory pattern given by the phosphonates in complement-dependent histamine release by rabbit anti-RGG is not a reflection of the capacity of rabbit serum to inactivate the phosphonates by enzymatic hydrolysis. Moreover, the fact that both the hemolytic-and histamine-releasing reactions involve cell suspensions obviates the possibility that differences in accessibility of the inhibitor to the target cell plays an appreciable role. Even though C'la (Table I) is required for complement-dependent histamine release by rabbit anti-RGG, this is not the esterase being blocked by the phosphonates when they inhibit this reaction.
The failure of the phosphonate esters to block the Cqa involved in the colnplement-dependent release of histamine is presumably on the same basis as their failure to prevent immune hemolysis by whole rabbit serum. At the relatively low dilution of rabbit serum used as a source of complement for histamine release or immune hemolysis, the rate of activation of C'lp to C'la exceeds the capacity of the phosphonate esters to inactivate sufficient C'la to block the reactions at this point. On the other hand, immune hemolysis by whole guinea pig complement can be blocked because the higher whole complement activity of guinea pig serura permits greater dilution of C'la (25) . As is evident from Fig. 2 , the prior activation of a relatively limited amount of rabbit C'la, as on the EAC~la r~b, 4*p cell, permits irreversible, progressive inactivation by the phosphonate esters. This suggests that a similar inhibition could be achieved by studying the effect of the phosphonates on histamine release from sensitized mast cells previously reacted with the first component of complement.
The same straight line relationship between the concentration of phosphonate and per cent inhibition of histamine release is found in the complement-dependent, noncytotoxic histamine release reaction (Fig. 3 ) and in homocytotropic antibody-mediated histamine release (reference 3, Fig. 3 ). This implies that in both reactions there is a critical step (s) subsequent to activation of the esterase which has the same mathematical dependence on the concentration of activated esterase. The pattern of inhibition by the phosphonates of the antigen-antibody-activated esterase required for complement-dependent histamine release is remarkably similar to that of the esterase required for homocytotropic antibodymediated histamine release. The phenylalkyl phosphonate series shows the same increase in inhibitory potency with an increase in alkyl chain length in both complement-dependent (Fig. 4, A) and homocytotropic antibody-mediated (reference 3, Fig. 4, A) histamine release. The 5-aminopentyl and 5-chloropentyl phosphonates were distinctly better inhibitors of both reactions (Table  VII; reference 3, Table IV ) than the pentyl phosphonate. In fact, the only difference in inhibition pattern between the two reactions was observed with the chloroalkyl series. In the complement-dependent histamine-releasing reaction, there was a progressive increase in inhibitory activity in going from the 2-chloroethyl to the 5-chloropentyl phosphonate (Fig. 4, B) . The homocytotropic antibody-mediated release of histamine differed from this insofar as there was little or no difference in the activity of the 3-chloropropyl and 4-chlorobutyl phosphonates (reference 3, Fig. 4, B) ; however, in going to the 5-chloropentyl phosphonate there was a further increase in inhibitory activity. With the many similarities in the pattern of phosphonate inhibition of the two reactions, the minor difference in the chloroalkyl phosphonate series is not considered significant.
An increase in potency with an increase in alkyl chain length of the phenylalkyl phosphonates is characteristic of the reaction of these phosphonates with chymotrypsin (29) . With chymotrypsin there is also an increase in activity of the chloroalkyl series with increasing chain length (30) . Thus, the antigen-antibody-activated esterases involved in the complement-dependent release of histamine and in the homocytotropic antibody-mediated release of histamine resemble chymotrypsin in their reactivity with the phenylalkyt and chloroalkyl phosphonates. They differ from chymotrypsin in their greater susceptibility to the 5-arninopentyl phosphonate relative to the pentyl phosphonate.
The Relationship of Complement-Dependent ttistamine Release by Rabbit Anti-RGG to Homocytotropic Antibody-Mediated Histamine Release.--Lepow
and Dias Da Silva (32) have shown that human anaphylotoxin formed in a fluid phase reaction using purified components can release histamine from rat peritoneal mast cells. Only the first four components of complement are required to generate human anaphylotoxin. Since the release of histamine from rat peritoneal mast cells sensitized with rabbif anti-RGG requires at least the first five components of human complement, the latter reaction is probably not mediated by anaphylotoxin.
The homocytotropic antibody-mediated release of histamine differs from the complement-dependent reaction in not needing complement and in requiring a unique rat immunoglobulin to sensitize the mast cell. This immunoglobulin is not rat IgG, IgM, of IgA (2) . Presumably, the complement-dependent, noncytotoxic reaction is initiated by an immune aggregate adsorbed to the target cell. Despite these differences there is a very great similarity in the pattern of inhibition given by the phosphonate esters in blocking these two reactions. One possible implication is that these two quite different modes of carrying out an antigen-antibody reaction on the rat mast cell lead to activation of the same esterase. It may be that these different ways of initiating histamine release have a final common pathway.
SI.IM~AR¥
There is an absolute requirement for C'I, C'2, C'4, C'3, and C'5 in releasing histamine from rat peritoneal mast cells sensitized with rabbit anti-rat gamma globulin. This conclusion is based upon the restoration of histamine-releasing capacity by adding highly purified complement components to sera deficient in one or more of these components. Of special advantage was the availability of sera from humans with inborn or acquired deficiencies in a single component.
The p-nitrophenyl ethyl phosphonates block this reaction by inhibiting an antigen-antibody-activated esterase which exists in a phosphonate resistant precursor state until activated by the interaction of the sensitized mast cell and serum complement. There is almost complete disparity between the ability of the phosphonates to inhibit complement-dependent histamine release by rabbit anfi-RGG and to inactivate C'la. Even though C'la is required for complementdependent histamine release by rabbit anti-RGG, this is not the esterase being blocked by the phosphonates under the experimental conditions used.
The pattern of inhibition by the phosphonates of the antigen-antibody-activated esterase required for complement-dependent, noncytotoxic histamine release is remarkably similar to that of the esterase required for homocytotropic antibody-mediated histamine release. One possible implication is that these two quite different modes of carrying out antigen-antibody-induced histamine release from rat peritoneal mast cells lead to activation of the same esterase and share a common pathway.
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